PRESS RELEASES
Extended Release Tablets Formulation Simplified (NEW)
19 Jul, 2012
PRESS RELEASE : - First time a ‘Ready-to-use’ extended release systems have been developed by scientists at our new R&D Centre. Instamodel compositions are not limited to one class of drugs, they could be applied to a broad range of drugs. This ultimately opens a new window for mid-sized pharmaceutical companies worldwide looking for shelf life management of products and offer more convenient treatment options to patients in a shortest possible time frame.
download
Plant safety at workplace by reducing human errors
6 Jun, 2012
Mr. Suresh Pareek NEWS & VIEWS : - Mr. Suresh Pareek, Managing Director, Ideal Cures, elaborates on the need for safety in pharmaceutical plants and the required measures in such manufacturing facilities, highlighting the significance of human behaviour and human error.
download
   
Ideal Cures R&D centre eyes ambitious plans for future
6 Jun, 2012
Mr. Suresh Pareek NEWS & VIEWS : - Ideal Cures research centre and application laboratory in Goregaon, Mumbai inagurated in February 2011. Spread over 14,000 sq feet. equipped with lab scale and scale-up facilities (machines, equipment and analytical instruments) to provide support for developing the complete range of oral solid dosage forms. This includes tablets (all types), hard gelatine capsules, pellets, spheres, acrylic polymers and modified release solid oral dosage forms.
download
Ideal Cures Introduces – Natural Sodium alginate based delayed release formulations System
21 May, 2012
PRESS RELEASE : - Instanute DR is ready to use enteric coating product and will help in maintaining efficacy of the active ingredient which are sensitive to high acidic pH in stomach. Through the use of Instanute DR, scientists will be able to program the release profile of the active ingredients ranging from 20-120 minutes. This is the first time Alginic Acid based composition has been developed to delay the release of drugs by film coating.
download
   
Ideal Cures Pvt. Ltd. receives key US Patent for sodium alginate based aqueous film coating technology
27 Mar, 2012
PRESS RELEASE : - Ideal Cures Pvt. Ltd. (ICPL) announces today that the United State Patent Office had granted important Patent US8123849 corresponding to Aqueous Film Coating Composition Containing Sodium Alginate and Preparation. Patent have estimated expiry in 2028. Patented invention provides breakthrough in film coating technology using sodium alginate which successfully removed requirement of organic solvents. This is for the first time natural polymer composition was used in fully aqueous system film coating technology.
download button
Ideal Cures launches INSTACOAT E Series film coating systems having ultra-fast coating offering Economical & Ecological benefits
23 Nov, 2011 07:46 CET

PRESS RELEASE : – The best advantage offered by the material is that the coating can be completed in less than 50% of the time, currently required with best of the materials available in the market. The product will be moderately priced, which will be suited to practically all the drug substances.

New e-series is a range of high performance coating products developed under Instacoat brand and consist of four coating systems. 1. High Performance Aqueous Film coating System 2. Efficient Moisture Barrier Aqueous Film Coating System 3. Optimized Weight Gain Hydro-alcoholic Enteric Film Coating System 4. Adhesion Aqueous Film Coating System
download button
   
Delayed release coating technology for nutritional supplements
NEWS & VIEWS : - Instanute DR is a new “pH dependent delay release ready to use film coating system” for food supplements accepted in EU and US. The reconstitution is easy, made in cold and stirred water as a common HPMC-based film coating system; the delayed release performances satisfy USP requirements for delayed release for pharma and nutritional products.
download button
“Entrepreneurship, team spirit and innovation has been the hall mark of Ideal Cures”
Mr. Suresh Pareek INTERVIEW : - Ideal Cures, the leading coating company and the recipient of the Nation Award 2009 has proved to be a leader in providing innovation products. Suresh Pareek, managing director, Ideal Cures speaks to Usha Sharma about their companies plans for further expansions.
download button
   
Ideal Cures opens new R&D centre, application lab for film coating systems

NEWS & VIEWS :- Ideal Cures research centre and application laboratory in Goregaon, Mumbai inaugurated in February 2011. Spread over 14,000 sq feet. equipped with lab scale and scale-up facilities (machines, equipment and analytical instruments) to provide support for developing the complete range of oral solid dosage forms. This includes tablets (all types), hard gelatine capsules, pellets, spheres, acrylic polymers and modified release solid oral dosage forms.

download button